Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Jul 2026 for XOMA Royalty Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Matthew d. Perry: trading record in brief
Matthew d. Perry has filed trades across 2 companies (mainly through SEC (Form 4)), most often in XOMA Royalty Corp and CTI Biopharma Corp. In total, 4 filings cover trades dated from 26 June 2023 to 14 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 14 July 2026, the filings show a transaction in XOMA Royalty Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Matthew d. Perry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
24,138 sharesCommon StockSEC:0001193125-26-303721:0
5,971 shares0Common StockSEC:0001214659-25-008321:0
6,070 shares0Common StockSEC:0001214659-24-009518:0
43,139 shares@ US$9.10100.0% of flowCommon StockSEC:0000899243-23-016484:0
4 of 4 declarations
